F&G年金人寿
FG
19.57
-0.04
-0.20%
F&G年金人寿
US · FG
#2506 按市值排名
上市于 1970
19.57
-0.04
-0.20%
实时 - 追踪5344个代码 - 心跳于452秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了6家。
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 97.79% -0.05pp
- 机构数量
- 400 -6
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Public Company75.50%
Mutual Fund18.95%
Individual/Insider2.25%
Hedge Fund1.81%
Government Pension Fund0.49%
Private Company0.43%
Sovereign Wealth Fund0.36%
Insurance Company0.21%
主要股东 截至 2026-06-30
Fidelity National Financial, Inc.
72.30% · 94.66M 股
BlackRock
2.58% · 3.38M 股
Brave Warrior Advisors, LLC
1.90% · 2.48M 股
Bank of America Corporation
1.70% · 2.22M 股
Dimensional Fund Advisors
1.63% · 2.14M 股
Vanguard Portfolio Management, LLC
1.51% · 1.98M 股
Vanguard Capital Management, LLC
1.36% · 1.79M 股
State Street Global Advisors
1.09% · 1.43M 股
Macquarie Investment Management Business Trust
0.96% · 1.26M 股
Columbia Management Investment Advisers, LLC
0.88% · 1.16M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 32次买入 · 16次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Fidelity National Financial, Inc. | -- | 72.30% |
| Christopher Blunt | Chief Executive Officer | 0.85% |
| William Foley | Executive Chairperson | 0.67% |
| Raymond Quirk | Director | 0.24% |
| Conor Murphy | Chief Financial Officer | 0.15% |
| Wendy Jane Young | Former Executive Vice President | 0.08% |
| Michael Nolan | Director | 0.06% |
| Douglas Ammerman | Independent Director | 0.05% |
| John Rood | Independent Director | 0.04% |
| Michael Gravelle | General Counsel | 0.04% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-30 | Douglas Ammerman | Independent Director | Other Acquisition | +1,013 | $21.98 |
| 2026-09-29 | Conor Murphy | Chief Financial Officer | Open Market Acquisition | +231 | $21.68 |
| 2026-09-13 | Michael Bailey | Chief Financial Officer | Other Acquisition | +26,817 | -- |
| 2026-08-02 | Michael Bailey | Chief Financial Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-06-30 | Raymond Quirk | Director | Other Acquisition | +1,009 | -- |
| 2026-06-30 | Douglas Ammerman | Independent Director | Other Acquisition | +816 | -- |
| 2026-06-30 | Michael Nolan | Director | Other Acquisition | +1,009 | -- |
| 2026-06-29 | Mark Wiltse | Former VP & Chief Accounting Officer of FGLH | Initial Statement of Beneficial | 0 | -- |
| 2026-03-31 | Raymond Quirk | Director | Other Acquisition | +1,067 | -- |
| 2026-03-31 | Douglas Ammerman | Independent Director | Other Acquisition | +863 | -- |
| 2026-03-31 | Conor Murphy | Chief Financial Officer | Sale to Issuer | -10,566 | $25.79 |
| 2026-03-31 | Michael Nolan | Director | Other Acquisition | +1,067 | -- |
| 2026-03-23 | Michael Gravelle | General Counsel | Sale to Issuer | -855 | $24.28 |
| 2026-03-12 | Christopher Blunt | Chief Executive Officer | Open Market Acquisition | +10,000 | $20.99 |
| 2026-03-12 | Celina J. Doka | Independent Director | Open Market Acquisition | +4,760 | $20.98 |
| 2026-02-26 | William Foley | Executive Chairperson | Sale to Issuer | -12,318 | $22.65 |
| 2026-02-26 | Christopher Blunt | Chief Executive Officer | Sale to Issuer | -20,846 | $22.65 |
| 2026-02-26 | Wendy Jane Young | Former Executive Vice President | Sale to Issuer | -4,142 | $22.65 |
| 2026-01-04 | Raymond Quirk | Director | Other Acquisition | +133,420 | $30.85 |
| 2026-01-04 | Douglas Ammerman | Independent Director | Other Acquisition | +9,059 | $30.85 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
F&G年金人寿 讨论区 0 条评论